New drug trial targets liver scarring in MASH patients

NCT ID NCT06903065

First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times

Summary

This early-stage study tests a new medicine called RO7790121 in 50 adults with advanced liver scarring from MASH (a type of fatty liver disease). The main goal is to see if the drug is safe and how the body processes it. Researchers will also check if it can reduce liver stiffness and improve markers of liver damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MASH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Adobe Clinical Research, LLC

    Tucson, Arizona, 85712, United States

  • Bellaire Clinical Research, LLC

    Bellaire, Texas, 77401, United States

  • Centro de Investigacion y Gastroenterologia

    Mexico City, Mexico CITY (federal District), 06700, Mexico

  • DHR Health Institute for Research and Development

    McAllen, Texas, 78504, United States

  • Delta Research Partners, LLC (Bastrop)

    Bastrop, Louisiana, 71220, United States

  • FDI Clinicial Research - Mayaguez

    Mayagez, 00680, Puerto Rico

  • Fundacion Santos Y De La Garza Evia IBP

    San Pedro Garza García, Nuevo León, 66278, Mexico

  • Fundacion de Investigacion de Diego

    San Juan, 00927, Puerto Rico

  • GI Alliance

    Southlake, Texas, 76092, United States

  • Gastrointestinal Specialists of Georgia, PC

    Marietta, Georgia, 30060, United States

  • Innovative Clinical Research

    Clarksville, Tennessee, 37040, United States

  • Jubilee Clinical Research NV, LLC

    Las Vegas, Nevada, 89106, United States

  • Pinnacle Clinical Research - Austin

    Austin, Texas, 78757, United States

  • Pinnacle Clinical Research Georgetown

    Georgetown, Texas, 78626, United States

  • Pinnacle Clinical Research, PLLC

    San Antonio, Texas, 78229, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.